Clinical Trials Browser

Melanoma × Hydroxychloroquine × 90 days × Clear all

NCT04464759 2026-05-11

LIMIT

Phase 1/2 Recruiting

Melanoma

NCT01480154 2026-04-13

Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer

Phase 1 Active not recruiting

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma, Prostatic Neoplasms